Literature DB >> 22620273

Use of specific-pathogen-free (SPF) rhesus macaques to better model oral pediatric cytomegalovirus infection.

Myra G dela Pena1, Lisa Strelow, Peter A Barry, Kristina Abel.   

Abstract

BACKGROUND: Congenital human cytomegalovirus (HCMV) infection can result in lifelong neurological deficits. Seronegative pregnant woman often acquire primary HCMV from clinically asymptomatic, but HCMV-shedding children.
METHODS: Potential age-related differences in viral and immune parameters of primary RhCMV infection were examined in an oral rhesus CMV infection model in specific pathogen free macaques. RhCMV shedding was measured by real time PCR in plasma, saliva and urine. Immune parameters, including neutralizing and binding antibodies and RhCMV-specific T cell responses, were assessed in longitudinally collected blood samples.
RESULTS: The oral RhCMV infection model in infant SPF rhesus macaques demonstrated that (i) the susceptibility to oral RhCMV infection declines with age, and (ii) infant macaques shed RhCMV more persistently and at higher titers compared to adult macaques. (iii)
CONCLUSIONS: The oral infant RhCMV infection model appears to reflect viral pathogenesis in human HCMV-infected children. Larger studies are needed to define immune parameters associated with better control of RhCMV in adult compared to young animals.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2012        PMID: 22620273      PMCID: PMC3367395          DOI: 10.1111/j.1600-0684.2012.00541.x

Source DB:  PubMed          Journal:  J Med Primatol        ISSN: 0047-2565            Impact factor:   0.667


  20 in total

1.  Partial efficacy of a VSV-SIV/MVA-SIV vaccine regimen against oral SIV challenge in infant macaques.

Authors:  Marta L Marthas; Koen K A Van Rompay; Zachary Abbott; Patricia Earl; Linda Buonocore-Buzzelli; Bernard Moss; Nina F Rose; John K Rose; Pamela A Kozlowski; Kristina Abel
Journal:  Vaccine       Date:  2011-03-04       Impact factor: 3.641

Review 2.  Cytomegalovirus infection in immunocompetent and immunocompromised individuals--a review.

Authors:  Z Vancíková; P Dvorák
Journal:  Curr Drug Targets Immune Endocr Metabol Disord       Date:  2001-08

3.  Breast milk and the risk of cytomegalovirus infection.

Authors:  S Stagno; D W Reynolds; R F Pass; C A Alford
Journal:  N Engl J Med       Date:  1980-05-08       Impact factor: 91.245

Review 4.  Group day care and cytomegaloviral infections of mothers and children.

Authors:  R F Pass; C Hutto
Journal:  Rev Infect Dis       Date:  1986 Jul-Aug

5.  Differential detection of B virus and rhesus cytomegalovirus in rhesus macaques.

Authors:  J L Huff; R Eberle; J Capitanio; S S Zhou; P A Barry
Journal:  J Gen Virol       Date:  2003-01       Impact factor: 3.891

6.  Persistent and selective deficiency of CD4+ T cell immunity to cytomegalovirus in immunocompetent young children.

Authors:  Wenwei Tu; Sharon Chen; Margaret Sharp; Corry Dekker; Anne Marie Manganello; Eileen C Tongson; Holden T Maecker; Tyson H Holmes; Zhaoti Wang; George Kemble; Stuart Adler; Ann Arvin; David B Lewis
Journal:  J Immunol       Date:  2004-03-01       Impact factor: 5.422

7.  Antiviral CD8 T cells in the control of primary human cytomegalovirus infection in early childhood.

Authors:  Sharon F Chen; Wen-Wei Tu; Margaret A Sharp; Eileen Cordoba Tongson; Xiao-Song He; Harry B Greenberg; Tyson H Holmes; Zhaoti Wang; George Kemble; Anne-Marie Manganello; Stuart P Adler; Cornelia L Dekker; David B Lewis; Ann M Arvin
Journal:  J Infect Dis       Date:  2004-04-16       Impact factor: 5.226

8.  Molecular epidemiology of cytomegalovirus: a study of factors affecting transmission among children at three day-care centers.

Authors:  S P Adler
Journal:  Pediatr Infect Dis J       Date:  1991-08       Impact factor: 2.129

9.  Experimental coinfection of rhesus macaques with rhesus cytomegalovirus and simian immunodeficiency virus: pathogenesis.

Authors:  Getachew Sequar; William J Britt; Fred D Lakeman; Kristen M Lockridge; Ross P Tarara; Don R Canfield; Shan-Shan Zhou; Murray B Gardner; Peter A Barry
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

10.  Antibody responses to rhesus cytomegalovirus glycoprotein B in naturally infected rhesus macaques.

Authors:  Yujuan Yue; Shan Shan Zhou; Peter A Barry
Journal:  J Gen Virol       Date:  2003-12       Impact factor: 3.891

View more
  7 in total

1.  Pathogenesis of Wild-Type-Like Rhesus Cytomegalovirus Strains following Oral Exposure of Immune-Competent Rhesus Macaques.

Authors:  Yujuan Yue; W L William Chang; Julia Li; Nancy Nguyen; Kimberli A Schmidt; Philip R Dormitzer; Xinzhen Yang; Peter A Barry
Journal:  J Virol       Date:  2021-11-17       Impact factor: 6.549

2.  Developing a Vaccine against Congenital Cytomegalovirus (CMV) Infection: What Have We Learned from Animal Models? Where Should We Go Next?

Authors:  Mark R Schleiss
Journal:  Future Virol       Date:  2013-12       Impact factor: 1.831

Review 3.  Rhesus monkeys for a nonhuman primate model of cytomegalovirus infections.

Authors:  Hannah L Itell; Amitinder Kaur; Jesse D Deere; Peter A Barry; Sallie R Permar
Journal:  Curr Opin Virol       Date:  2017-09-06       Impact factor: 7.090

Review 4.  A fifty-year odyssey: prospects for a cytomegalovirus vaccine in transplant and congenital infection.

Authors:  Don Jeffrey Diamond; Corinna La Rosa; Flavia Chiuppesi; Heidi Contreras; Sanjeet Dadwal; Felix Wussow; Supriya Bautista; Ryotaro Nakamura; John A Zaia
Journal:  Expert Rev Vaccines       Date:  2018-10-03       Impact factor: 5.217

5.  Intrahost cytomegalovirus population genetics following antibody pretreatment in a monkey model of congenital transmission.

Authors:  Diana Vera Cruz; Cody S Nelson; Dollnovan Tran; Peter A Barry; Amitinder Kaur; Katia Koelle; Sallie R Permar
Journal:  PLoS Pathog       Date:  2020-02-14       Impact factor: 6.823

6.  Murine Cytomegalovirus Exploits Olfaction To Enter New Hosts.

Authors:  Helen E Farrell; Clara Lawler; Cindy S E Tan; Kate MacDonald; Kimberley Bruce; Michael Mach; Nick Davis-Poynter; Philip G Stevenson
Journal:  MBio       Date:  2016-04-26       Impact factor: 7.867

Review 7.  There Is Always Another Way! Cytomegalovirus' Multifaceted Dissemination Schemes.

Authors:  Joseph W Jackson; Tim Sparer
Journal:  Viruses       Date:  2018-07-20       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.